InvestorsHub Logo

nidan7500

05/09/19 9:13 AM

#192156 RE: drv17 #192153

drv17:I think we should propose that long term shareholders be provided with a "Priority Prescription" so that we would first in line to receive this drug.


Excellent suggestion. I plan to have my dose plan prescription delivered as 2x12 oz bottles of Coors Light per day.

oldandintheway

05/09/19 9:44 AM

#192161 RE: drv17 #192153

And dose that priority prescription with extra-strength exedrin to deal with the chronically shi**y price action.

leaping frog

05/09/19 10:22 AM

#192181 RE: drv17 #192153

LOL? Why? You have proposed a serious Shareholder Rights program.

GrassyKnoll

05/09/19 11:04 AM

#192194 RE: drv17 #192153

Actually you might not be that far from the truth about a week ago I discussed an interview with Patrick for the CEO of overstock. Overstock has a small division that is seating what is SEDING enqueue A bunch of very small block chain start up’s. One of the start ups he talked about was a company that has an option on a moth board General Motors plant and what we Siana. The company has a design for an 84 mile per gallon car that will cost under $7000. The company needs just a few hundred million and start up money to get going. The company came to Patrick to see if he would help make a block chain coin to help finance the start of the company. The holder of the coin could claim or wine Car I am very sorry for Siri screwing this up but I’m doing the best I can so to repeat each coin could be used for one car. The coins would be good for a one out of every seven cars once everything was up and running. The coins could be traded on a block chain. Early investors might be able to buy a coin for a steep discount. Portions of coins could be divided and sold in the market. All of this could be done on a public block chain. Now why am I talking about all of this. Because and I don’t know if anybody else could have caught this but I am saying this because Mr. Patrick burn of overstock went on to say that he had been approached by a company in the Alzheimer’s space to see if a similar capital raising device could be used to finance the development of an Alzheimer’s drug. I wonder if the person that approached mr. Patrick Byrne spoke with a funny German accent and had a funny hair do?